We have previously reported that TLR9 deficiency in B cells reduces pro-inflammatory signaling pathways by upregulating interleukin-10 (IL-10) secretion and this reduces the incidence of T1D in NOD mice (8). Here, IL10 is linked to type 1 diabetes mellitus.